Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, ImmunityBio (IBRX) has a market cap of $2.45 billion USD. According to our data, ImmunityBio is ranked No.3663 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $2.45 B |
31.24%
|
| Dec 31, 2024 | $1.87 B |
-49.00%
|
| Dec 29, 2023 | $3.67 B |
-0.99%
|
| Dec 30, 2022 | $3.70 B |
-16.61%
|
| Dec 31, 2021 | $4.44 B |
-54.39%
|
| Dec 31, 2020 | $9.73 B |
251.72%
|
| Dec 31, 2019 | $2.77 B |
226.72%
|
| Dec 31, 2018 | $0.85 B |
-74.16%
|
| Dec 29, 2017 | $3.28 B |
-21.50%
|
| Dec 30, 2016 | $4.18 B |
-66.99%
|
| Dec 31, 2015 | $12.65 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioNTech
BNTX
|
$23.80 B |
0.001 M
|
Germany
|
 Novavax
NVAX
|
$1.03 B |
0.000 M
|
USA
|
 Inovio Pharmaceuticals
INO
|
$64.55 M |
0.000 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
| Market Cap | = | IBRX Stock Price | * | IBRX Shares Outstanding |
| = | $2.78 | * | 0.88 B | |
| = | $2.45 B |